Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions

NCT00217269 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT00217269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2005
Completion date
July 31, 2011
Enrollment
1,548 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease